We are harnessing the power of the immune system to cure disease by using nature’s most effective search engine: Adaptive Immunity
Pioneering the next generation of antibody therapeutics for hard to treat diseases
Nature’s Most Effective
Our unique approach identifies groups of resilient individuals, such as long-term survivors of cancer, to learn how they overcome or resist disease.
Using leading-edge science and deep learning, we create therapeutics from those antibodies present across the resilient population.
Alchemab Therapeutics to present data profiling a novel antibody to Huntingtin Exon 1 at the CHDI Annual Huntington’s Disease Therapeutics Conference
Alchemab Therapeutics and Medicines Discovery Catapult awarded £1.7 million grant from Innovate UKto accelerate development of disease-modifying therapy for Huntington’s Disease